BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8293570)

  • 1. The mechanism of coronary collateral vasoconstriction in response to cyclooxygenase blockade.
    Altman JD; Bache RJ
    Circ Res; 1994 Feb; 74(2):310-7. PubMed ID: 8293570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin on coronary collateral blood flow.
    Altman JD; Dulas D; Pavek T; Bache RJ
    Circulation; 1993 Feb; 87(2):583-9. PubMed ID: 8425302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels.
    Altman J; Dulas D; Bache RJ
    Circ Res; 1992 Jun; 70(6):1091-8. PubMed ID: 1576731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
    Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
    J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium.
    Traverse JH; Judd D; Bache RJ
    Circulation; 1996 Feb; 93(3):558-66. PubMed ID: 8565176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase blockade limits blood flow to collateral-dependent myocardium during exercise.
    Altman JD; Klassen CL; Bache RJ
    Cardiovasc Res; 1995 Nov; 30(5):697-704. PubMed ID: 8595615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of canine coronary collateral vessels to ergonovine and alpha-adrenergic stimulation.
    Bache RJ; Foreman B; Hautamaa PV
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1019-25. PubMed ID: 1681740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary collagen: effects on coronary collateral circulation and the role of thromboxane.
    Klassen CL; Bache RJ
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):90-5. PubMed ID: 10892665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet activation on coronary collateral blood flow.
    Kinn JW; Bache RJ
    Circulation; 1998 Oct; 98(14):1431-7. PubMed ID: 9760298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function in well-developed canine coronary collateral vessels.
    Altman J; Dulas D; Pavek T; Laxson DD; Homans DC; Bache RJ
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H567-72. PubMed ID: 8447468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcitonin gene-related peptide on well-developed canine coronary collateral vasculature.
    Quebbeman BB; Dulas D; Altman J; Homans DC; Bache RJ
    J Cardiovasc Pharmacol; 1993 May; 21(5):774-80. PubMed ID: 7685448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasomotor responses of newly developed coronary collateral vessels.
    Kinn JW; Altman JD; Chang MW; Bache RJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):H490-7. PubMed ID: 8770088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atrial natriuretic peptide on coronary collateral blood flow.
    Foreman B; Dai XZ; Homans DC; Laxson DD; Bache RJ
    Circ Res; 1989 Dec; 65(6):1671-8. PubMed ID: 2531047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
    Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
    Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
    Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
    Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomotor properties of immature canine coronary collateral circulation.
    Hautamaa PV; Dai XZ; Homans DC; Robb JF; Bache RJ
    Am J Physiol; 1987 Jun; 252(6 Pt 2):H1105-11. PubMed ID: 3109257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional significance of alpha-adrenergic receptors in mature coronary collateral circulation of dogs.
    Maruoka Y; McKirnan MD; Engler RL; Longhurst JC
    Am J Physiol; 1987 Sep; 253(3 Pt 2):H582-90. PubMed ID: 2888319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
    Martin SE; Kuvin JT; Offenbacher S; Odle BM; Patterson RE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor activity of moderately well-developed canine coronary collateral circulation.
    Hautamaa PV; Dai XZ; Homans DC; Bache RJ
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H890-7. PubMed ID: 2466413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise.
    Foreman BW; Dai XZ; Bache RJ
    Circ Res; 1991 Sep; 69(3):657-64. PubMed ID: 1873862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.